ArticleThe journal of physical chemistry letters2026
A Transferable and Robust Computational Framework for Class A GPCR Activation Free Energies.
Article in The journal of physical chemistry letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cross-talk of filter gate and lower helices drives polymodal regulation and disease in TREK channels.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The activation of G-protein coupled receptors is involved in many biomedically important cellular pathways. However, capturing it with molecular simulations is far from trivial, as it requires capturing both local and global motions. We recently achieved this goal in a specific receptor (the β1-adrenergic receptor, or ADRB1) by combining a multiple replica enhanced sampling approach with tailored collective variables. While that approach can be applied to other receptors, it would require a tedious and error-prone choice and refinement of the collective variables and, in particular, of the main path-like variable. Herein, we introduce an effective and streamlined evolved strategy for defining CVs that reduces user intervention while still achieving a robust free energy convergence. We apply it to two apo-GPCRs of pharmacological relevance, ADRB1 and the μ-opioid receptor. In the first case, we show that the reconstructed free energies agree with those obtained with the previous tailored approach, while for the μ-opioid receptor activation, we gain novel biological insights. The proposed method can be easily applied to other class A GPCRs, paving the way for the systematic elucidation of the activation mechanisms of many crucial drug targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.